ORCID as entered in ROS
https://orcid.org/0000-0002-0009-3337
Select Publications
Conference Papers
, 2011, 'SEQUENCE SPECIFIC INDUCTION OF HIV-1 TRANSCRIPTIONAL GENE SILENCING TARGETING NF-kappa B SEQUENCES BY SIRNA WITHOUT ANY OFF-TARGET EFFECTS OF OTHER NF-kappa B DRIVEN GENES', in JOURNAL OF GENE MEDICINE, WILEY-BLACKWELL, AUSTRALIA, Univ Melbourne, Bio21 Inst, Parkville, pp. 425 - 425, presented at
, 2011, 'Performance of quantiferon-cmv (r) and whole-blood cd4(+)cd25(+)cd134(+) assays in identification of human cytomegalovirus-specific t-cells in children post-haematopoietic stem cell transplantation', in Internal Medicine Journal, Blackwell Publishing Asia, http://dx.doi.org/10.1111/%28ISSN%291445-5994
, 2011, 'Primary Immune Responses to Vaccinia Virus Vaccination: The Role of Cytotoxic Effector CD4+ T Cells in the Generation of Human T Cell Memory', in AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, pp. A129 - A139
, 2010, 'Most HIV DNA in PBMC is present in non-gut-homing, resting central memory CD4 T-cells', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Dubrovnik, CROATIA, pp. A44 - A44, presented at
, 2009, 'Evaluation of adipose gene expression and mitochondrial DNA in healthy adults over a 6 week course of NRTI and/or PI treatment. Indications of divergent effects', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A10 - A11, presented at
, 2008, 'HLA Footprints in HIV-1 Drive Phylogenetic Clustering and Inter-Clade Variation', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT INC, SOUTH AFRICA, Cape Town, pp. 75 - 75, presented at
, 2008, 'Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial', in Lancet, pp. 1881 - 1893, http://dx.doi.org/10.1016/S0140-6736(08)61591-3
, 2008, 'Early CD8+T Cell Responses are the Major Contributors to the Later Viral Set Point', in AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Larchmont, NY, USA, pp. 7 - 7, presented at
, 2008, 'Long-term Stability of Compensated CTL Escape Mutations following Acute HIV Infection', in AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Larchmont, NY, USA, pp. 78 - 78, presented at
, 2008, 'Reversion of HLA-Associated Polymorphisms in Gag, Pol and Nef during the First Year of HIV Infection: Sites, Rates and pVL Correlations', in AIDS Research and Human Retroviruses, Mary Ann Liebert Inc, Larchmont, NY, USA, pp. 76 - 77, presented at
, 2006, 'Transient CCR5+ CD38+++ CD4+ effector TH1 cells are an early component of the primary immune response to vaccinia and immediately precede IL-2+ memory CD4+ T cells', in CYTOMETRY PART A, Wiley-Liss, pp. 400 - 400
, 2005, 'Optimizing 9-colour analysis of gut-homing CD4+T cell subsets', in CYTOMETRY PART A, WILEY-LISS, AUSTRIA, Queensland, pp. 400 - 400, presented at
, 2005, 'Development and optimisation of a culture amplified multiparametric intraceilular cytokine assay for the assessment of vaccine immunogenicity', in Tissue Antigens, Blackwell Munksgaard, pp. 499 - 499
, 2005, 'TCR clonotypic analysis of CMV antigen-specific CD8+ T-cells from formaldehyde fixed peripheral blood', in Tissue Antigens, Blackwell Munksgaard, pp. 573 - 574
, 2003, 'HIV Lipodystrophy Case Definition Study Group. Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. 57 - 57
, 2003, 'Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. L73 - L73
, 2002, 'Disrupted expression of lipid transport genes in monocytes of individuals with HIV-associated lipodystrophy - an additional risk for cardiovascular disease?', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L8 - L9, presented at
, 1998, 'Restoration of immunity with antiretroviral therapy', in AIDS, LIPPINCOTT WILLIAMS & WILKINS, pp. S3 - S3, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000077311300010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1997, 'Therapeutic vaccination with p24-VLP and AZT augments HIV specific CTL activity in asymptomatic HIV-infected individuals.', in Australasian Society for HIV Medicine 9th Annual Conference, Adelaide, Sth Aust, presented at
, 1997, 'CD8 activation does not totally normalise in treated primary HIV infection despite undetectable viral load; evidence for ongoing viral replication?', in 6th European Conference on Clinical Aspects and Treatment of HIV-Infection, Hamburg, Germany, presented at
, 1997, 'Reversal of CD8 activation in patients with primary HIV infection treated with AZT, 3TC and indinavir.', in 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ontario, Canada, presented at
, 1997, 'Reversal of lymphocyte RA/RO ratios in patients with primary HIV infection treated with zidovudine, lamivudine and indinavir.', in International Workshop on HIV Drug Resistance, Treatment Strategies and Eradication, St Petersburg, Florida, USA, presented at
, 1997, 'Effect of therapeutic vaccine p24-VLP and AZT on immunological and virological markets in asymptomatic subjects', in 4th Conference on Retrovirology and Opportunistic Infections, Washington DC, USA, presented at
, 1996, 'Can antiviral therapy restore immune function?', in AIDS, RAPID SCIENCE PUBLISHERS, pp. 23 - 23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VU96300005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1996, 'Effects of therapeutic vaccination (p24-VLP) and AZT on immunological and virological markers in asymptomatic subjects', in 3rd International Congress on Drug Therapy in HIV Infection, Birmingham, England, pp. 137 - 137, presented at
, 1990, 'LIMITED ROLE OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN UNSELECTED PATIENTS WITH CEREBRAL ISCHEMIC EVENTS', in CIRCULATION, AMER HEART ASSOC, pp. 110 - 110, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1990EC76400454&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Conference Presentations
, 2020, 'A novel analysis of NSW HIV surveillance data to highlight HIV prevention program impact and gaps', presented at HIV&AIDS + Sexual Health 2020 Virtual, Virtual, 16 April 2020 - 20 November 2020, http://dx.doi.org/10.26190/unsworks/27986
, 2014, 'Acute tumor necrosis factor administration induces transient epithelial cell shedding, mucosal leak and neutrophil recruitment to the gut in a mouse model'
Conference Abstracts
, 2024, 'Cost-effectiveness of interventions to prevent vertical transmission of HIV in Papua New Guinea', in Cost-effectiveness of interventions to prevent vertical transmission of HIV in Papua New Guinea, Sydney, presented at 45th Australian Health Economics Society (AHES) Conference, Sydney, 19 September 2024 - 20 September 2024
, 2024, 'Costs and budget impact of scaling up clinic-based HIV viral load and infant diagnostic testing in Papua New Guinea', in Costs and budget impact of scaling up clinic-based HIV viral load and infant diagnostic testing in Papua New Guinea, Sydney, presented at 45th Australian Health Economics Society (AHES) Conference, Sydney, 19 September 2024 - 20 September 2024
, 2024, 'Costs of establishing clinic-based viral load and infant diagnostic testing and HIV drug resistance monitoring in Papua New Guinea', in Costs of establishing clinic-based viral load and infant diagnostic testing and HIV drug resistance monitoring in Papua New Guinea, Sydney, presented at Australasian HIV&AIDS Conference, Sydney, 19 September 2024 - 20 September 2024
, 2023, 'The journey of blood: working with point-of care technologies for HIV viral load testing and infant diagnosis in Papua New Guinea', in The journey of blood: working with point-of care technologies for HIV viral load testing and infant diagnosis in Papua New Guinea, Brisbane, presented at International AIDS Society Conference on HIV Science, Brisbane, 23 July 2023 - 26 July 2024
, 2023, 'ACTUP-PNG – a model for scaling up point-of-care HIV Viral Load and Early Infant Diagnosis in Papua New Guinea and other resource limited settings', in ACTUP-PNG – a model for scaling up point-of-care HIV Viral Load and Early Infant Diagnosis in Papua New Guinea and other resource limited settings, Brisbane, presented at International AIDS Society (IAS) Conference, Brisbane, 23 July 2023 - 26 July 2023
, 2023, 'Acceptability of point-of-care viral load testing for children <10 years and infant diagnosis in Papua New Guinea', in Acceptability of point-of-care viral load testing for children <10 years and infant diagnosis in Papua New Guinea, Brisbane, presented at International Workshop on HIV & Pediatrics, Brisbane
, 2023, 'Layer-by-Layer Particles Deliver Epigenetic Silencing siRNA to HIV-1 Latent Reservoir Cell Types', in Molecular Pharmaceutics, Vol. 20, pp. 2039 - 2052, http://dx.doi.org/10.1021/acs.molpharmaceut.2c01030
, 2023, 'Faster results, better care - implementing point of care HIV testing in two sites in Papua New Guinea', in Faster results, better care - implementing point of care HIV testing in two sites in Papua New Guinea, Sydney, presented at 1st Australasian Conference on Point Of Care Testing for Infectious Diseases (POC23), Sydney
, 2022, 'ANTI-SARS-COV-2 HYPERIMMUNE GLOBULIN FROM CONVALESCENT PLASMA: ACTIVITY & POTENTIAL APPLICATIONS', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 52, pp. 25 - 26, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862654200068&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2022, 'PATIENT PERCEPTIONS OF HEALTH-RELATED QUALITY OF LIFE IN AN AUSTRALIAN ADULT PRIMARY IMMUNODEFICIENCY COHORT', in INTERNAL MEDICINE JOURNAL, WILEY, Vol. 52, pp. 27 - 27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862654200072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2021, 'RNA-directed gene therapy protects CD4+T cells during HIV challenge and delays virus rebound post-ART in humanized mice', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 24, pp. 10 - 10, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000713652900022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2020, 'Delivering Epigenetic Silencing Sirna to the Nucleus of Hiv-1 Infected Primary Activated Cd4+T-Cells via Nanoparticle System', in MOLECULAR THERAPY, CELL PRESS, ELECTR NETWORK, Vol. 28, pp. 468 - 469, presented at 23rd Annual Meeting of the American-Society-for-Gene-and-Cell-Therapy, ELECTR NETWORK, 12 May 2020 - 15 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000530089302176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Clearance of HPV anal premalignant lesions and modulation of systemic immune responses to HPV oncogenes with low dose pomalidomide', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SWITZERLAND, Geneva, Vol. 30, presented at Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO), SWITZERLAND, Geneva, 11 December 2019 - 14 December 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000506799900104&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Tissue-based activation of mucosal-associated invariant T (MAIT) cells in combination ipilimumab and nivolumab checkpoint inhibitor (CI) colitis', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SPAIN, Barcelona, Vol. 30, pp. 530 - 530, presented at 44th Congress of the European-Society-for-Medical-Oncology (ESMO), SPAIN, Barcelona, 27 September 2019 - 01 October 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000491295503349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2019, 'Characterisation of peripheral blood mononuclear cells in patients with combination ipilimumab and nivolumab therapy-related colitis', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, AUSTRIA, Vienna, Vol. 110, pp. S21 - S22, presented at 6tth International Cancer Immunotherapy Conference in Europe (ITOC), AUSTRIA, Vienna, 11 April 2019 - 13 April 2019, http://dx.doi.org/10.1016/j.ejca.2019.01.072
, 2018, 'Modular gene therapy vectors for gene therapy cure in resting immune cells', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 21, pp. 4 - 4, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440002700009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'HIV treatment prevents HIV transmission in male serodiscordant couples in Australia, Thailand and Brazil', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 20, pp. 115 - 115, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000406429800213&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'Accumulation of follicular T Helper (Tfh) cells, despite preferential infection, allows establishment of a large and unexpected viral reservoir during HIV infection', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 264 - 264, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400533&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'T-cells in the anal mucosa of men with high- grade squamous intraepithelial lesions', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 240 - 240, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400486&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2016, 'The primary immune response to vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T cell phenotype', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, Vol. 46, pp. 676 - 677, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016
, 2015, 'COMPARISON OF THE FREELITE (TM) SERUM FREE LIGHT CHAIN (SFLC) ASSAY WITH SERUM AND URINE ELECTROPHORESIS/IMMUNOFIXATION AND THE N LATEX FLC ASSAY', in INTERNAL MEDICINE JOURNAL, WILEY-BLACKWELL, Vol. 45, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000360834700077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'T-CELLS IN THE ANAL MUCOSA OF MEN WITH HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, Vol. 91, pp. A168 - A168
Filter by type
https://orcid.org/0000-0002-0009-3337